Hypogonadotropic Hypogonadism Revisited

Detalhes bibliográficos
Autor(a) principal: Fraietta, Renato [UNIFESP]
Data de Publicação: 2013
Outros Autores: Zylberstejn, Daniel Suslik [UNIFESP], Esteves, Sandro C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.6061/clinics/2013(Sup01)09
http://repositorio.unifesp.br/handle/11600/35766
Resumo: Impaired testicular function, i.e., hypogonadism, can result from a primary testicular disorder (hypergonadotropic) or occur secondary to hypothalamic-pituitary dysfunction (hypogonadotropic).Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). the incidence of congenital hypogonadotropic hypogonadism is approximately 1-10:100,000 live births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism, respectively.Acquired hypogonadotropic hypogonadism can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful. in Kallmann syndrome, cerebral MRI can show an anomalous morphology or even absence of the olfactory bulb. Therapy for hypogonadotropic hypogonadism depends on the patient's desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism. Androgen replacement is indicated for men who already have children or have no desire to induce pregnancy, and testosterone therapy is used to reverse the symptoms and signs of hypogonadism. Conversely, GnRH or gonadotropin therapies are the best options for men wishing to have children. Hypogonadotropic hypogonadism is one of the rare conditions in which specific medical treatment can reverse infertility.When an unassisted pregnancy is not achieved, assisted reproductive techniques ranging from intrauterine insemination to in vitro fertilization to the acquisition of viable sperm from the ejaculate or directly from the testes through testicular sperm extraction or testicular microdissection can also be used, depending on the woman's potential for pregnancy and the quality and quantity of the sperm.
id UFSP_0c09329e183e15dbfcdc0dbaf89e86cb
oai_identifier_str oai:repositorio.unifesp.br/:11600/35766
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Hypogonadotropic Hypogonadism RevisitedMale InfertilityHypogonadismEndocrine System AbnormalitiesAzoospermiaReviewImpaired testicular function, i.e., hypogonadism, can result from a primary testicular disorder (hypergonadotropic) or occur secondary to hypothalamic-pituitary dysfunction (hypogonadotropic).Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). the incidence of congenital hypogonadotropic hypogonadism is approximately 1-10:100,000 live births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism, respectively.Acquired hypogonadotropic hypogonadism can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful. in Kallmann syndrome, cerebral MRI can show an anomalous morphology or even absence of the olfactory bulb. Therapy for hypogonadotropic hypogonadism depends on the patient's desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism. Androgen replacement is indicated for men who already have children or have no desire to induce pregnancy, and testosterone therapy is used to reverse the symptoms and signs of hypogonadism. Conversely, GnRH or gonadotropin therapies are the best options for men wishing to have children. Hypogonadotropic hypogonadism is one of the rare conditions in which specific medical treatment can reverse infertility.When an unassisted pregnancy is not achieved, assisted reproductive techniques ranging from intrauterine insemination to in vitro fertilization to the acquisition of viable sperm from the ejaculate or directly from the testes through testicular sperm extraction or testicular microdissection can also be used, depending on the woman's potential for pregnancy and the quality and quantity of the sperm.Fed Univ São Paulo UNIFESP, Dept Surg, Div Urol, São Paulo, BrazilANDROFERT Androl & Human Reprod Clin, Campinas, SP, BrazilFed Univ São Paulo UNIFESP, Dept Surg, Div Urol, São Paulo, BrazilWeb of ScienceHospital Clinicas, Univ São PauloUniversidade Federal de São Paulo (UNIFESP)ANDROFERT Androl & Human Reprod ClinFraietta, Renato [UNIFESP]Zylberstejn, Daniel Suslik [UNIFESP]Esteves, Sandro C.2016-01-24T14:30:59Z2016-01-24T14:30:59Z2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion81-88application/pdfhttp://dx.doi.org/10.6061/clinics/2013(Sup01)09Clinics. São Paulo: Hospital Clinicas, Univ São Paulo, v. 68, p. 81-88, 2013.10.6061/clinics/2013(Sup01)09S1807-59322013001300009.pdf1807-5932S1807-59322013001300009http://repositorio.unifesp.br/handle/11600/35766WOS:000316127300009engClinicsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T04:51:51Zoai:repositorio.unifesp.br/:11600/35766Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-01T04:51:51Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Hypogonadotropic Hypogonadism Revisited
title Hypogonadotropic Hypogonadism Revisited
spellingShingle Hypogonadotropic Hypogonadism Revisited
Fraietta, Renato [UNIFESP]
Male Infertility
Hypogonadism
Endocrine System Abnormalities
Azoospermia
Review
title_short Hypogonadotropic Hypogonadism Revisited
title_full Hypogonadotropic Hypogonadism Revisited
title_fullStr Hypogonadotropic Hypogonadism Revisited
title_full_unstemmed Hypogonadotropic Hypogonadism Revisited
title_sort Hypogonadotropic Hypogonadism Revisited
author Fraietta, Renato [UNIFESP]
author_facet Fraietta, Renato [UNIFESP]
Zylberstejn, Daniel Suslik [UNIFESP]
Esteves, Sandro C.
author_role author
author2 Zylberstejn, Daniel Suslik [UNIFESP]
Esteves, Sandro C.
author2_role author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
ANDROFERT Androl & Human Reprod Clin
dc.contributor.author.fl_str_mv Fraietta, Renato [UNIFESP]
Zylberstejn, Daniel Suslik [UNIFESP]
Esteves, Sandro C.
dc.subject.por.fl_str_mv Male Infertility
Hypogonadism
Endocrine System Abnormalities
Azoospermia
Review
topic Male Infertility
Hypogonadism
Endocrine System Abnormalities
Azoospermia
Review
description Impaired testicular function, i.e., hypogonadism, can result from a primary testicular disorder (hypergonadotropic) or occur secondary to hypothalamic-pituitary dysfunction (hypogonadotropic).Hypogonadotropic hypogonadism can be congenital or acquired. Congenital hypogonadotropic hypogonadism is divided into anosmic hypogonadotropic hypogonadism (Kallmann syndrome) and congenital normosmic isolated hypogonadotropic hypogonadism (idiopathic hypogonadotropic hypogonadism). the incidence of congenital hypogonadotropic hypogonadism is approximately 1-10:100,000 live births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome (KS) and idiopathic hypogonadotropic hypogonadism, respectively.Acquired hypogonadotropic hypogonadism can be caused by drugs, infiltrative or infectious pituitary lesions, hyperprolactinemia, encephalic trauma, pituitary/brain radiation, exhausting exercise, abusive alcohol or illicit drug intake, and systemic diseases such as hemochromatosis, sarcoidosis and histiocytosis X.The clinical characteristics of hypogonadotropic hypogonadism are androgen deficiency and a lack/delay/stop of pubertal sexual maturation. Low blood testosterone levels and low pituitary hormone levels confirm the hypogonadotropic hypogonadism diagnosis. A prolonged stimulated intravenous GnRH test can be useful. in Kallmann syndrome, cerebral MRI can show an anomalous morphology or even absence of the olfactory bulb. Therapy for hypogonadotropic hypogonadism depends on the patient's desire for future fertility. Hormone replacement with testosterone is the classic treatment for hypogonadism. Androgen replacement is indicated for men who already have children or have no desire to induce pregnancy, and testosterone therapy is used to reverse the symptoms and signs of hypogonadism. Conversely, GnRH or gonadotropin therapies are the best options for men wishing to have children. Hypogonadotropic hypogonadism is one of the rare conditions in which specific medical treatment can reverse infertility.When an unassisted pregnancy is not achieved, assisted reproductive techniques ranging from intrauterine insemination to in vitro fertilization to the acquisition of viable sperm from the ejaculate or directly from the testes through testicular sperm extraction or testicular microdissection can also be used, depending on the woman's potential for pregnancy and the quality and quantity of the sperm.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
2016-01-24T14:30:59Z
2016-01-24T14:30:59Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.6061/clinics/2013(Sup01)09
Clinics. São Paulo: Hospital Clinicas, Univ São Paulo, v. 68, p. 81-88, 2013.
10.6061/clinics/2013(Sup01)09
S1807-59322013001300009.pdf
1807-5932
S1807-59322013001300009
http://repositorio.unifesp.br/handle/11600/35766
WOS:000316127300009
url http://dx.doi.org/10.6061/clinics/2013(Sup01)09
http://repositorio.unifesp.br/handle/11600/35766
identifier_str_mv Clinics. São Paulo: Hospital Clinicas, Univ São Paulo, v. 68, p. 81-88, 2013.
10.6061/clinics/2013(Sup01)09
S1807-59322013001300009.pdf
1807-5932
S1807-59322013001300009
WOS:000316127300009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinics
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 81-88
application/pdf
dc.publisher.none.fl_str_mv Hospital Clinicas, Univ São Paulo
publisher.none.fl_str_mv Hospital Clinicas, Univ São Paulo
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268303279915008